Neutrophil to Lymphocyte Ratio in Myelofibrosis Patients Treated with Ruxolitinib May Predict Prognosis and Rate of Discontinuation.
European Journal Of Haematology（2024）
Key words
DIPSS,IPSS,myelofibrosis,neutrophil-to-lymphocyte ratio (NLR),overall survival (OS),Ruxolitinib (ruxo)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined